IOVANCE BIOTHERAPEUTICS, INC. Other Nonoperating Income (Expense)
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Other Nonoperating Income (Expense) of $200.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-11.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2016-03-11
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2014-12-31 was $1.81K, a 196.24% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2014-09-30 was $4.19K.
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2014-06-30 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for the quarter ending 2013-12-31 was $611.00, a 99.99% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2015 was $200.00K, a 3233.33% increase from fiscal 2014.
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2014 was $6.00K.
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2013 was -$2.74M, a 156.81% decline from fiscal 2012.
- IOVANCE BIOTHERAPEUTICS, INC. other nonoperating income (expense) for fiscal 2012 was $4.82M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed | Other Nonoperating Income (Expense) 48 month | Other Nonoperating Income (Expense) 51 month | Other Nonoperating Income (Expense) 54 month | Other Nonoperating Income (Expense) 57 month | Other Nonoperating Income (Expense) 60 month | Other Nonoperating Income (Expense) 63 month | Other Nonoperating Income (Expense) 66 month | Other Nonoperating Income (Expense) 69 month | Other Nonoperating Income (Expense) 72 month | Other Nonoperating Income (Expense) 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $200.00K 10-K · filed 2016-03-11 | |||||||||||||||
| 2014-12-31 | $1.81K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $6.00K derived: sum of 2 quarters · filed 2016-03-11 | $6.00K derived: sum of 3 quarters · filed 2016-03-11 | $6.00K 10-K · filed 2016-03-11 | $5.66K 10-K · filed 2015-03-16 | |||||||||||
| 2014-09-30 | $4.19K 10-Q · filed 2014-11-13 | $4.19K derived: sum of 2 quarters · filed 2014-11-13 | $4.19K 10-Q · filed 2014-11-13 | |||||||||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | ||||||||||||||
| 2014-03-31 | -$3.18M 10-Q · filed 2014-05-14 | |||||||||||||||
| 2013-12-31 | $611.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $611.00 derived: sum of 2 quarters · filed 2016-03-11 | -$2.40M derived: sum of 3 quarters · filed 2016-03-11 | -$2.74M 10-K · filed 2016-03-11 | -$2.74M 10-K · filed 2014-03-28 | -$3.18M 10-K · filed 2014-03-28 | ||||||||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | -$2.40M derived: sum of 2 quarters · filed 2014-11-13 | -$2.74M 10-Q · filed 2014-11-13 | $2.45M derived: sum of 4 quarters · filed 2014-11-13 | -$3.18M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | -$2.40M 10-Q · filed 2014-08-08 | -$2.74M 10-Q · filed 2014-08-08 | $2.45M derived: sum of 3 quarters · filed 2014-08-08 | $3.40M derived: sum of 4 quarters · filed 2014-08-08 | -$3.18M 10-Q · filed 2013-10-23 | |||||||||||
| 2013-03-31 | -$341.62K 10-Q · filed 2014-05-14 | $4.85M derived: sum of 2 quarters · filed 2014-05-14 | $5.80M derived: sum of 3 quarters · filed 2014-05-14 | $7.12M derived: sum of 4 quarters · filed 2014-05-14 | -$784.69K 10-Q · filed 2013-10-23 | |||||||||||
| 2012-12-31 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $6.14M derived: sum of 2 quarters · filed 2014-03-28 | $7.46M derived: sum of 3 quarters · filed 2014-03-28 | $4.82M 10-K · filed 2014-03-28 | -$443.08K 10-K · filed 2013-09-23 | |||||||||||
| 2012-09-30 | $953.74K 10-Q · filed 2013-11-14 | $953.74K 10-Q · filed 2013-01-25 | $2.27M derived: sum of 2 quarters · filed 2013-11-14 | -$364.02K 10-Q · filed 2013-11-14 | -$4.53M derived: sum of 4 quarters · filed 2013-11-14 | -$5.63M 10-Q · filed 2013-01-25 | ||||||||||
| 2012-06-30 | $1.32M 10-Q · filed 2013-10-23 | -$1.32M 10-Q · filed 2013-10-23 | -$5.48M derived: sum of 3 quarters · filed 2013-10-23 | -$5.49M derived: sum of 4 quarters · filed 2013-10-23 | -$6.59M 10-Q/A · filed 2012-09-10 | |||||||||||
| 2012-03-31 | -$2.64M 10-Q · filed 2013-10-23 | -$6.80M derived: sum of 2 quarters · filed 2013-10-23 | -$6.81M derived: sum of 3 quarters · filed 2013-10-23 | -$7.21M derived: sum of 4 quarters · filed 2013-10-23 | -$7.90M 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | -$4.17M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | -$4.17M derived: sum of 2 quarters · filed 2013-09-23 | -$4.57M derived: sum of 3 quarters · filed 2013-09-23 | -$4.48M 10-K · filed 2013-09-23 | -$5.27M 10-K · filed 2012-03-30 | |||||||||||
| 2011-09-30 | -$4.34K 10-Q · filed 2013-01-25 | -$402.89K derived: sum of 2 quarters · filed 2013-01-25 | -$308.94K 10-Q · filed 2013-01-25 | -$554.78K derived: sum of 4 quarters · filed 2013-01-25 | -$1.10M 10-Q · filed 2011-11-21 | |||||||||||
| 2011-06-30 | -$398.56K 10-Q/A · filed 2012-09-10 | -$304.60K 10-Q/A · filed 2012-09-10 | -$550.45K derived: sum of 3 quarters · filed 2012-09-10 | -$1.10M derived: sum of 4 quarters · filed 2012-09-10 | ||||||||||||
| 2011-03-31 | $93.95K 10-Q · filed 2012-05-15 | -$151.89K derived: sum of 2 quarters · filed 2012-05-15 | -$698.62K derived: sum of 3 quarters · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | -$245.84K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$792.58K derived: sum of 2 quarters · filed 2012-03-30 | -$792.58K 10-K · filed 2012-03-30 | |||||||||||||
| 2010-09-30 | -$546.73K 10-Q · filed 2011-11-21 | -$546.73K 10-Q · filed 2011-11-21 | ||||||||||||||
| 2009-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |